Use of XXXX for testing ovarian reserve: a survey of 796 infertility clinics worldwide.

@entity52 @entity248
PURPOSE: The aim of this study is to assess how @entity248 ( @entity248 ) is used worldwide to test ovarian reserve and guide @entity52 ( @entity52 ) cycle management. METHODS: An internet-based survey was sent electronically to registered @entity52 providers within the @entity52 -Worldwide.com network. This survey consisted of nine questions which assessed the clinics' use of @entity248 . The questionnaire was completed online through the @entity52 -Worldwide.com website, and quality assurance tools were used to verify that only one survey was completed per clinical @entity52 center. Results are reported as the proportion of @entity52 cycles represented by a particular answer choice. RESULTS: Survey responses were completed from 796 globally distributed @entity52 clinics, representing 593,200 @entity52 cycles worldwide. Sixty percent of the respondent- @entity52 cycles reported to use @entity248 as a first line test, and 54 % reported it as the best test for evaluating ovarian reserve. Eighty-nine percent reported that @entity248 results were extremely relevant or relevant to clinical practice. However in contrast, for predicting live birth rate, 81 % reported age as the best predictor. CONCLUSIONS: @entity248 is currently considered a first line test for evaluating ovarian reserve and is considered relevant to clinical practice by the majority of @entity52 providers.
